3
Announcements
Trials
Browse
Landscape
Status
Completed
31
Terminated
10
Unknown
5
Withdrawn
2
Active not recruiting
2
Recruiting
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Hodgkin Disease
1
Interventions
fludarabine phosphate
3
venetoclax
2
navitoclax
2
fludarabine
2
zanubrutinib
1
sugemalimab
1
plerixafor
1
nilotinib
1
midostaurin
1
loncastuximab tesirine
1
eryaspase
1
ceritinib
1
asparaginase erwinia chrysanthemi recombinant
1
Whole-Body Irradiation
1
Tacrolimus
1
Mycophenolic Acid
1
Cytarabine
1
Cyclophosphamide
1
Cord Blood Stem Cell Transplantation
1
Busulfan
1
Brentuximab Vedotin
1
Bone Marrow Transplantation
1
Bendamustine Hydrochloride
1
Asparaginase
1
AP 1903 reagent
1
4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
plerixafor
×
Lymphoid
×
Clear all
NCT00720603
2015-03-24
EAP
Sanofi
No longer available